title: Toluidine blue O and methylene blue as endothelial redox probes in the intact lung.
abstract: There is increasing evidence that the redox activities of the pulmonary endothelial surface may have important implications for the function of both lungs and blood. Because of the inherent complexity of intact organs, it can be difficult to study these activities in situ. Given the availability of appropriate indicator probes, the multiple-indicator dilution (MID) method is one approach for dealing with some aspects of this complexity. Therefore, the objectives of the present study were to 1) evaluate the potential utility of two thiazine redox indicators, methylene blue (MB) and toluidine blue O (TBO), as MID electron acceptor probes for in situ pulmonary endothelium and 2) develop a mathematical model of the pulmonary disposition of these indicators as a tool for quantifying their reduction on passage through the lungs. Experiments were carried out using isolated rabbit lungs perfused with physiological salt solution with or without plasma albumin over a range of flow rates. A large fraction of the injected TBO disappeared from the perfusate on passage through the lungs. The reduction of its oxidized, strongly polar, relatively hydrophilic blue form to its colorless, highly lipophilic reduced form was revealed by the presence of the reduced form in the venous effluent when plasma albumin was included in the perfusate. MB was also lost from the perfusate, but the fraction was considerably smaller than for TBO. A distributed-in-space-and-time model was developed to estimate the reduction rate parameter, which was approximately 29 and 1.0 ml/s for TBO and MB, respectively, and almost flow rate independent for both indicators. The results suggest the utility particularly of TBO as an electron acceptor probe for MID studies of in situ pulmonary endothelium and of the model for quantitative evaluation of the data.
authors.affiliation: Department of Biomedical Engineering, Marquette University, Milwaukee 53201-1881, USA.
authors.forename: S H
authors.initials: SH
authors.lastname: Audi
authors.forename: L E
authors.initials: LE
authors.lastname: Olson
authors.forename: R D
authors.initials: RD
authors.lastname: Bongard
authors.forename: D L
authors.initials: DL
authors.lastname: Roerig
authors.forename: M L
authors.initials: ML
authors.lastname: Schulte
authors.forename: C A
authors.initials: CA
authors.lastname: Dawson
mesh_terms: D000818:Animals; D004396:Coloring Agents / Q000493:pharmacokinetics*; D004730:Endothelium, Vascular / Q000378:metabolism*; D066298:In Vitro Techniques; D007201:Indicator Dilution Techniques; D008751:Methylene Blue / Q000493:pharmacokinetics*; D008955:Models, Cardiovascular; D010084:Oxidation-Reduction; D010477:Perfusion; D011652:Pulmonary Circulation; D011817:Rabbits; D014048:Tolonium Chloride / Q000493:pharmacokinetics*
chemical_list: D004396:Coloring Agents; D014048:Tolonium Chloride; D008751:Methylene Blue